| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1368960 | Bioorganic & Medicinal Chemistry Letters | 2015 | 5 Pages |
Abstract
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
A series of highly active C-aryl glucoside SGLT2 inhibitors containing a biphenyl motif were designed and synthesized for biological evaluation. Among the compounds tested, compound 16l demonstrated high inhibitory activity against SGLT2 (IC50 = 1.9 nM) with an excellent pharmacokinetic profile. Further study indicated that the in vivo efficacy of compound 16l was comparable to that of dapagliflozin, suggesting that further development would be worthwhile.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Yuyang Ding, Liufeng Mao, Dengfeng Xu, Hui Xie, Ling Yang, Hongjiang Xu, Wenjun Geng, Yong Gao, Chunguang Xia, Xiquan Zhang, Qingyi Meng, Donghai Wu, Junling Zhao, Wenhui Hu,